Le Lézard
Classified in: Health

LGC Maine Standards Expands VALIDATE® Body Fluids Product Line for Easier and Cost Effective Laboratory Developed Test (LDT) Validation and Documentation of Linearity


CUMBERLAND FORESIDE, Maine, Oct. 16, 2018 /PRNewswire-PRWeb/ -- LGC Maine Standards has expanded its innovative Body Fluids product line, VALIDATE® Body Fluids, Order Number 205bf, for easier linearity and calibration verification.

The kit, in a simulated body fluid matrix, will assist in the documentation of linearity, calibration verification and verification of the reportable range for Albumin (ALB), Amylase (AMY), Cholesterol (CHOL), Creatinine (CREA), Glucose (GLU), Lactate (LAC), Lactate dehydrogenase (LD), Total protein2 (TP), Triglycerides (TRIG), and Urea Nitrogen (UN). Each VALIDATE® Body Fluids kit, liquid and ready-to-use, prepared using the CLSI EP06-A "equal delta" sample preparation, offers five distinct concentrations to establish the reportable range. Simply dispense the solution from each dropper bottle, directly into five sample cups, and run in replicates.

VALIDATE® Body Fluids is the only comprehensive, commercially available calibration verification solution on the market allowing clinical laboratories to complete their required Body Fluids linearity and calibration verification, validation of in-house methods or laboratory developed tests (LDT) for analytes in body fluids ? maximizing the reportable range while minimizing manual dilutions. Use of this product, while augmenting daily QC, assists with fulfilling various quality control requirements ? such as Analytical Measurement Range (AMR) and Reportable Range ? for linearity and calibration verification under CLIA '88, CAP, COLA, JCAHO, JCI and ISO 15189.

The addition of VALIDATE® Body Fluids to the LGC Maine Standards expanding portfolio of products demonstrates a continued commitment to manufacture high-quality linearity and calibration verification products that meet industry needs.

LGC Maine Standards is located in Cumberland Foreside, Maine and manufactures VALIDATE® linearity and calibration verification kits for over 137 analytes, including General Chemistries, Urine Chemistries, Enzymes, Lipids, HbA1c, Therapeutic Drugs, Cardiac Markers, Thyroids, Serum Proteins, Vitamin D, Tumor Markers, Anemia, Fertility, Hemostasis, Whole Blood Glucose, and Body Fluids.

LGC Maine Standards MSDRx® data reduction software is available at no charge for real-time data analysis or a laboratory can send their data to LGC Maine Standards where a technical specialist will complete the data analysis and return a report within five business days. Peer group comparison is also available upon request.

Contact: Maine Standards Company, LLC 221 US Route 1, Cumberland Foreside, ME 04110 1-207-892-1300 x1473 [email protected]

About LGC

LGC is an international life sciences measurement and testing company with leading positions in growing markets. LGC provides a range of measurement products and services which underpin the safety, health and security of the public, including reference materials and proficiency testing, calibration verification / linearity testing, genomics reagents and instrumentation, and expert sample analysis and interpretation. LGC serves customers across a number of end markets including Pharmaceuticals, Agricultural Biotechnology, Food, Environment, Government and Academia.
LGC's headquarters are in London and the company employs over 2,000 people, operating out of 22 countries worldwide. Its operations are extensively accredited to international quality standards such as ISO/IEC 17025, GMP, GLP, ISO Guide 34, ISO/IEC 17043 and ISO 13485:2003.

With a history dating back to 1842, LGC has been home to the UK Government Chemist for more than 100 years and is the UK National Measurement Laboratory and Designated Institute for chemical and bio measurement. LGC was privatized in 1996 and is now owned by funds affiliated with KKR.

For more information, please visit http://www.lgcgroup.com.

 

SOURCE LGC


These press releases may also interest you

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

23 avr 2024
Astellas Pharma Inc....



News published on and distributed by: